Log in to save to my catalogue

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation...

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9924094

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer (S1416): a randomised, phase 2 trial

About this item

Full title

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer (S1416): a randomised, phase 2 trial

Journal title

The lancet oncology, 2023-01, Vol.24 (2), p.162-174

Language

English

Formats

More information

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9924094

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9924094

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(22)00739-2

How to access this item